Bulletin
Investor Alert

New York Markets Close in:

Annovis Bio Inc.

NYS: ANVS

GO
/marketstate/country/us

Market open

/zigman2/quotes/216213707/composite

$

18.62

Change

-1.46 -7.27%

Volume

Volume 89,845

Feb 7, 2023, 2:15 p.m.

Real time quotes

/zigman2/quotes/216213707/composite

Previous close

$ 20.08

$ 18.62

Change

-1.46 -7.27%

Day low

Day high

$18.12

$20.07

Open
Open: 19.68

52 week low

52 week high

$8.39

$23.91

Open

Market cap

$163.93M

Average volume

52,365

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-3.45

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/anvs

MarketWatch News on ANVS

  1. Annovis Bio stock price target cut to $70 from $150 at Maxim Group

    6:43 a.m. Oct. 8, 2021

    - Tomi Kilgore

  2. Analyst Raises Price Targets on 3 Smaller Alzheimer's Stocks

    10:50 a.m. July 7, 2021

    - Barron's Online

  3. Annovis Bio stock price target raised to $150 from $45 at Maxim Group

    7:30 a.m. July 7, 2021

    - Tomi Kilgore

  4. Annovis Bio stock price target raised to $45 from $12 at Maxim Group

    6:33 a.m. May 13, 2021

    - Tomi Kilgore

  5. Annovis Bio started at buy with $12 stock price target at Maxim Group

    6:57 a.m. June 18, 2020

    - Tomi Kilgore

/news/nonmarketwatch/company/us/anvs

Other News on ANVS

  1. Annovis (ANVS) Gains on FDA Authorization for AD Study

    11:57 a.m. Oct. 7, 2022

    - Zacks.com

  2. ANVS, ARQQ and ALLG among mid-day movers

    12:04 p.m. Sept. 12, 2022

    - Seeking Alpha

  3. 10-Q: ANNOVIS BIO, INC.

    10:46 a.m. Aug. 8, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. GOGL, PRTY and ANVS are among pre market gainers

    7:33 a.m. July 7, 2022

    - Seeking Alpha

  5. Anavex's Blarcamesine: Why It May Treat Alzheimer's Disease

    6:28 p.m. June 2, 2022

    - Seeking Alpha

  6. Loading more headlines...
/news/pressrelease/company/us/anvs

Press Releases on ANVS

  1. Annovis Bio to Present at the 2022 ThinkEquity Investor Conference

    6:31 a.m. Oct. 20, 2022

    - PR Newswire - PRF

  2. Annovis Bio's CEO Maria Maccecchini Issues Letter to Stockholders

    6:30 a.m. Sept. 8, 2022

    - PR Newswire - PRF

  3. Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer

    3:00 p.m. Aug. 29, 2022

    - PR Newswire - PRF

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.